These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29396233)
1. In Vivo Evaluation of the Synergic Effect of Metformin and mTOR Inhibitors on the Endothelial Healing of Drug-eluting Stents in Diabetic Patients. Cubero-Gallego H; Romaguera R; Gómez-Lara J; Gómez-Hospital JA; Sabaté M; Pinar E; Gracida M; Roura G; Ferreiro JL; Teruel L; Tebé-Codorni C; Jiménez-Quevedo P; Montanya E; Alfonso F; Cequier Á Rev Esp Cardiol (Engl Ed); 2018 Nov; 71(11):917-925. PubMed ID: 29396233 [TBL] [Abstract][Full Text] [Related]
2. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography. Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691 [TBL] [Abstract][Full Text] [Related]
3. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
4. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial. Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254 [TBL] [Abstract][Full Text] [Related]
5. Rationale and study design of the RESERVOIR trial: a randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus. Romaguera R; Brugaletta S; Gomez-Lara J; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Gómez-Hospital JA; Montanya E; Alfonso F; Valgimigli M; Sabate M; Cequier A Catheter Cardiovasc Interv; 2015 Mar; 85(4):E116-22. PubMed ID: 25380051 [TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA; JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410 [TBL] [Abstract][Full Text] [Related]
7. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation. de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783 [TBL] [Abstract][Full Text] [Related]
9. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study. Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068 [TBL] [Abstract][Full Text] [Related]
10. Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study. Otsuki S; Brugaletta S; Sabaté M; Shiratori Y; Gomez-Monterrosas O; Scalone G; Romero-Villafañe S; Hernández-Enríquez M; Freixa X; Martín-Yuste V; Masotti M Cardiovasc Revasc Med; 2016 Jun; 17(4):241-7. PubMed ID: 27158001 [TBL] [Abstract][Full Text] [Related]
11. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients. Miyazaki T; Latib A; Panoulas VF; Miyazaki S; Costopoulos C; Sato K; Naganuma T; Kawamoto H; Daida H; Colombo A Catheter Cardiovasc Interv; 2015 Jul; 86(1):E11-8. PubMed ID: 25534499 [TBL] [Abstract][Full Text] [Related]
13. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Morino Y; Tanabe K; Kadota K; Kimura T; EuroIntervention; 2015 Sep; 11(5):564-71. PubMed ID: 26390517 [TBL] [Abstract][Full Text] [Related]
14. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent. Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291 [TBL] [Abstract][Full Text] [Related]
16. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy. Terashita D; Otake H; Shinke T; Murasato Y; Kinoshita Y; Yamawaki M; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K; Hirata K Can J Cardiol; 2016 Mar; 32(3):384-90. PubMed ID: 26481078 [TBL] [Abstract][Full Text] [Related]
17. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up. Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862 [TBL] [Abstract][Full Text] [Related]
20. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents. Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]